Previous 10 | Next 10 |
2024-02-01 18:02:59 ET More on SEP Acquisition Corp., SANUWAVE Health, etc. Sanuwave Health sees Q4 record revenue $6.6M-$6.8M, up 20% Y/Y Financial information for SEP Acquisition Corp. Financial information for SANUWAVE Health Read the full article on See...
EDEN PRAIRIE, MN, Jan. 22, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced the Company is holding a special meeting...
2024-01-10 08:14:02 ET More on SANUWAVE Health Financial information for SANUWAVE Health For further details see: Sanuwave Health sees Q4 record revenue $6.6M-$6.8M, up 20% Y/Y
SANUWAVE is pleased to announce preliminary revenues of $6.6 million to $6.8 million for the fourth quarter ended December 31, 2023. This represents a new quarterly revenue record for the Company. Q4 2023 revenue increased 20% to 24% over Q4 2022 and in excess of 30% versus the third quart...
2023-11-10 05:05:07 ET More on SANUWAVE Health Sanuwave Health eyes Nasdaq listing, announces merger with SEP Acquisition Financial information for SANUWAVE Health For further details see: SANUWAVE Health GAAP EPS of -$0.03, revenue of $5M; initiates Q4 outlook
EDEN PRAIRIE, MN,, Nov. 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced its 3rd quarter 2023 results. ...
EDEN PRAIRIE, MN - ( NewMediaWire ) - November 08, 2023 - SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation wound care products, will host a live conference call on Friday, November 10, 2023, at 8:00AM (ET) to present the Q3 2023 financial results. ...
2023-10-10 07:56:17 ET SANUWAVE Health ( OTCQB:SNWV ) expects Q3 revenue in the range of $4.7 to $4.9 million. “Overall revenues in the quarter were positively impacted by significant growth in the core UltraMIST product lines which constituted greater than 90% of SANUWAVE&...
SANUWAVE is Pleased to Announce Preliminary Revenues of $4.7 Million to $4.9 Million for the Third Quarter Ended September 30, 2023 Results Indicate 13-18% Growth Rate Over Q3 2022 UltraMist Revenues (systems and consumables) Increased in Excess of 25% Year On Year and by Greater Th...
2023-08-23 17:06:42 ET More on SEP Acquisition Corp., SANUWAVE Health, etc. SANUWAVE to share monthly performance data SANUWAVE Health says shares will no longer be traded on OTC market SANUWAVE Health inks $3M private placement financing SANUWAVE Health inks...
News, Short Squeeze, Breakout and More Instantly...
Sanuwave Health Inc Company Name:
SNWV Stock Symbol:
OTCMKTS Market:
EDEN PRAIRIE, MN - ( NewMediaWire ) - May 07, 2024 - SANUWAVE Health, Inc. (the "Company" or "Sanuwave”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, May 10, 2024, at 8:30 AM (ET) to present the Q1 2024 f...
SANUWAVE is pleased to announce preliminary revenues of $5.7 million to $5.9 million for the first quarter ended March 31, 2024. This represents the highest Q1 revenues in company history. Q1 2024 revenue increased between 51% and 56% compared to Q1 2023. UltraMist revenues for Q1 2...
Sorensen brings strong finance, forecasting, analysis, and capital markets experience as well as abilities in software, process automation, and h...